Structure of the mammalian NOS regulator dimethylarginine dimethylaminohydrolase: A basis for the design of specific inhibitors

被引:57
作者
Frey, Daniel [1 ]
Braun, Oliver [1 ]
Briand, Christophe [1 ]
Vasak, Milan [1 ]
Grutter, Markus G. [1 ]
机构
[1] Univ Zurich, Dept Biochem, CH-8057 Zurich, Switzerland
关键词
D O I
10.1016/j.str.2006.03.006
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Dimethylarginine dimethylaminohydrolase (DDAH) is involved in the regulation of nitric oxide synthase (NOS) by metabolizing the free endogenous arginine derivatives N-omega-methyl-L-arginine(MMA) and N-omega,N-omega-dimethyl-L-arginine (ADMA), which are competitive inhibitors of NOS. Here, we present high-resolution crystal structures of DDAH isoform 1 (DDAH-1) isolated from bovine brain in complex with different inhibitors, including S-nitroso-L-homocysteine and Zn2+, a regulator of this mammalian enzyme. The structure of DDAH-1 consists of a propeller-like fold similar to other arginine-modifying enzymes and a flexible loop, which adopts different conformations and acts as a lid at the entrance of the active site. The orientation and interaction mode of inhibitors in the active site give insight into the regulation and the molecular mechanism of the enzyme. The presented structures provide a basis for the structure-based development of specific DDAH-1 inhibitors that might be useful in the therapeutic treatment of NOS dysfunction-related diseases.
引用
收藏
页码:901 / 911
页数:11
相关论文
共 52 条
[1]   Analysis of zinc binding sites in protein crystal structures [J].
Alberts, IL ;
Nadassy, K ;
Wodak, SJ .
PROTEIN SCIENCE, 1998, 7 (08) :1700-1716
[2]   GW274150 and GW273629 are potent and highly selective inhibitors of inducible nitric oxide synthase in vitro and in vivo [J].
Alderton, WK ;
Angell, ADR ;
Craig, C ;
Dawson, J ;
Garvey, E ;
Moncada, S ;
Monkhouse, J ;
Rees, D ;
Russell, LJ ;
Russell, RJ ;
Schwartz, S ;
Waslidge, N ;
Knowles, RG .
BRITISH JOURNAL OF PHARMACOLOGY, 2005, 145 (03) :301-312
[3]   The Cambridge Structural Database: a quarter of a million crystal structures and rising [J].
Allen, FH .
ACTA CRYSTALLOGRAPHICA SECTION B-STRUCTURAL SCIENCE, 2002, 58 (3 PART 1) :380-388
[4]   Structural basis for Ca2+-induced activation of human PAD4 [J].
Arita, K ;
Hashimoto, H ;
Shimizu, T ;
Nakashima, K ;
Yamada, M ;
Sato, M .
NATURE STRUCTURAL & MOLECULAR BIOLOGY, 2004, 11 (08) :777-783
[5]   THE CCP4 SUITE - PROGRAMS FOR PROTEIN CRYSTALLOGRAPHY [J].
BAILEY, S .
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1994, 50 :760-763
[6]   Plasma concentration of asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, is elevated in monkeys with hyperhomocyst(e)inemia or hypercholesterolemia [J].
Böger, RH ;
Bode-Böger, SM ;
Sydow, K ;
Heistad, DD ;
Lentz, SR .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2000, 20 (06) :1557-1564
[7]   Characterization of dimethylargininase from bovine brain:: Evidence for a zinc binding site [J].
Bogumil, R ;
Knipp, M ;
Fundel, SM ;
Vasák, M .
BIOCHEMISTRY, 1998, 37 (14) :4791-4798
[8]   NITRIC-OXIDE - A PHYSIOLOGICAL MESSENGER MOLECULE [J].
BREDT, DS ;
SNYDER, SH .
ANNUAL REVIEW OF BIOCHEMISTRY, 1994, 63 :175-195
[9]  
Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/s0907444998003254
[10]   The dual personality of NO [J].
Colasanti, M ;
Suzuki, H .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2000, 21 (07) :249-252